Therapeutic Advances in Gastroenterology: "Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease."<br>Gut (British Society of Gastroenterology): "Which 5-ASA?"<br>Johns Hopkins Medicine: "Ulcerative Colitis."<br>Mayo Clinic: "Ulcerative Colitis: Diagnosis & Treatment."<br>Cleveland Clinic: "Corticosteroids."<br>Harvard Health Publishing: "Ulcerative Colitis."<br>CDC.gov: "What is inflammatory bowel disease (IBD)?"<br>National Center for Biotechnology Information: "Biologics & Biosimilars."<br>UChicagoMedicine: "Inflammatory Bowel Disease Treatment."<br>CADTH Rapid Response Report: Peer Reviewed Summary With Critical Appraisal: "Biologics versus Immunomodulators for the treatment of Ulcerative Colitis: A Review of Comparable Clinical Effectiveness & Cost Effectiveness."<br>UpToDate.com: "Ulcerative Colitis: Beyond the Basics."